AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

2-Day Conference: Circulating Biomarkers, Exosomes & Liquid Biopsy - Asia 2019 (Seoul, South Korea - September 9-10, 2019) - ResearchAndMarkets.com

February 14, 2019

DUBLIN--(BUSINESS WIRE)--Feb 14, 2019--The “Circulating Biomarkers, Exosomes & Liquid Biopsy Asia 2019” conference has been added to ResearchAndMarkets.com’s offering.

This conference brings together a focus on technology development as well as applications for biomarker analysis in cancer, cardiovascular disease and other disease classes.

The conference focuses heavily on the various classes of circulating biomarkers and emphasizes the many technology platforms currently being utilized to interrogate Circulating Cell-Free DNA (cfDNA), Circulating Tumor Cells (CTCs) and Extracellular Vesicles (EVs)/Exosomes.

The potential of EVs/Exosomes for Therapeutics Development and Delivery are Presented as well as the Potential of EVs derived from Stem Cells for Regenerative Medicine.

This conference also features a showcase of companies involved in the study of cfDNA, CTCs and Exosomes and technologies in this space.

Korea is an excellent venue for this Asia/Pacific conference with a very strong scientific and technology focus and extensive research in this space plus the excellent conference location in Seoul is accessible from around the world to maximize networking and partnering activities at this conference.

Agenda

  • Circulating Biomarker Classes (Circulating Cell-Free DNA, Circulating Tumor Cells, Exosomes)
    • Biomarker Cargo
    • Technologies for Isolation and Analysis
  • Extracellular Vesicles (EVs)/Exosomes
    • Classes of Biomarkers (RNA, DNA, Protein)
    • Engineering, Delivery Vehicles and Therapeutics Development
    • Technologies for Study
  • Liquid Biopsy Development
    • Clinical Development and Pipeline
    • Regulatory Landscape in Asia
    • Technologies for Implementing using Biofluids

For more information about this conference visit https://www.researchandmarkets.com/research/svmtr3/2day_conference?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190214005502/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biomarkers

KEYWORD: ASIA PACIFIC SOUTH KOREA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/14/2019 08:43 AM/DISC: 02/14/2019 08:43 AM

http://www.businesswire.com/news/home/20190214005502/en